CHICAGO, June 11, 2019 - Sheridan Capital Partners (“Sheridan”) announced today its investment in Atlantic Vision Partners (“AVP” or the “Company”), a vision practice management company. In the transaction, Sheridan invested alongside AVP’s founders and management, who will retain a meaningful ownership stake in the business.
AVP, headquartered in Richmond, VA, serves ophthalmology and optometry clinics throughout Virginia. The Company has achieved significant scale in its core markets, while maintaining a reputation for providing excellent patient care for over 30 years.
“AVP has achieved meaningful scale in its geography,” said Jonathan Lewis, Partner of Sheridan Capital Partners. “The Company has grown significantly due to the team’s focus on clinical excellence and its ability to attract strong provider talent to the platform.”
“We believe Sheridan represents the perfect partner for us given their history in this kind of setting,” said Michael Holton, Chief Executive Officer of AVP. “The investment team has extensive experience building leading physician practice management businesses, and we look forward to growing AVP together with our team of doctors and managers.”
The transaction was led by Jonathan Lewis, Sean Dempsey, Alex Kain, and Matt Hinshaw at Sheridan Capital Partners. Twin Brook Capital Partners provided debt financing for the transaction. McGuireWoods LLP served as legal counsel to Sheridan Capital Partners. Terms of the transaction were not disclosed.
Sheridan Capital Partners (“SCP”) is a Chicago-based healthcare private equity firm that focuses on lower middle market buyouts and growth equity in the U.S. and Canada. SCP partners with companies that have enterprise values from $25 million to $150 million, bringing strategic resources to accelerate growth, build enduring value, and achieve strong results.
For additional information or inquiries, please contact: